Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical SR-T100 gel for cutaneous squamous cell carcinoma in situ
ISRCTN30540872Phase 2Completed
- Sponsor
- G&E Herbal Biotech
- Start
- Dec 2007
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of SR-T100 in Bowen disease (BD) and actinic keratosis (AK), sponsored by G&E Herbal Biotech. Primary endpoint: Response rate. Started Dec 2007; status: completed.
02
Drugs
SR-T100
03
Conditions
Bowen disease (BD)actinic keratosis (AK)
Beyond the preview
Go deeper on ISRCTN30540872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30540872.